Drug Profile
Mycobacterium vaccae vaccine - Immune Network
Alternative Names: Heat-inactivated M. vaccae pill; tableted heat-inactivated mycobacterium vaccae; Tubivac; V-7; V-7 ImmunitorLatest Information Update: 22 Mar 2022
Price :
$50
*
At a glance
- Originator Immune Network; Immunitor
- Class Antituberculars; Tuberculosis vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Tuberculosis
Most Recent Events
- 22 Mar 2022 No development reported - Phase-II for Tuberculosis (Adjunctive treatment) in Argentina (PO) (NCT01380119)
- 22 Mar 2022 No development reported - Phase-III for Tuberculosis in Ukraine, Mongolia (PO) (NCT01977768)
- 22 Mar 2022 Mycobacterium vaccae vaccine receives Orphan Drug status for Tuberculosis in USA